Skip to main content
OpenTrials
Completed

NCT Number: NCT01943578

Value of Physical Capacity Tests in Lung Cancer

The study examines the physical capacity of lung cancer patients assessed with the six minute walk test and handgrip strength. Demographic and selfreported exercise behavior is registered to explore correlations to functional and physical capacity.

Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non Small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Small Cell Lung Cancer Small Cell Lung Carcinoma Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Copenhagen

Copenhagen, 2200, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non small cell lung cancer stage I-IV
  • Small cell lung cancer
  • Patients >18 years
  • WHO performance status 0-2
  • undergoing chemotherapy

Exclusion criteria

  • unstable angina during the previous month
  • myocardial infarction diagnosed within the last month
  • not approval for physical activity by primary oncologist
  • inability to provide informed consent.

Treatment and study plan

Primary outcomes

  1. Mortality - Survival time

    Time frame: time from first chemotherapy treatment to death, assessed after 30 months

    Prognostic value of the six minute walk and handgrip strength on mortality

Secondary outcomes

  1. Hand grip strength

    Time frame: before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.

  2. Self reported exercise behavior

    Time frame: before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.

  3. Six minute walk test

    Time frame: Before first and after fourth chemotheraphy cycle, an expected average of 12 weeks between first and second assessment.

Other outcomes

  1. FACT-L

    Time frame: Before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment.

    Patient reported outcome

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

Prospective Observational Cohort Study of the Value of the Six Minute Walk Test and Handgrip Strength in Lung Cancer Patients Undergoing Chemotherapy

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Sep 17, 2013
Registry last updated
Nov 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.